Bioquell Share News (BQE)

Bioquell names Michael Roller as the new Finance Director

Bio-decontamination equipment products manufacturer Bioquell announced on Tuesday the appointment of Michael Roller as the group's new Finance Director. Roller qualified as an accountant with KPMG and has ample experience in the finance function, including within the life sciences sector. His mo

Bioquell Appoints Michael Roller As New Group Finance Director

LONDON (Alliance News) - Bioquell PLC, the bio-decontamination and containment equipment and products manufacturer, said Tuesday that it has appointed Michael Roller as its new group finance director. Roller has previously held the position of finance director at a number of quoted companie

Bioquell Expects Revenues And Orders Ahead Of Previous Year

LONDON (Alliance News) - Bioquell PLC said Friday that it expects revenue and orders for the full year ended December 31 to be ahead of the previous year. The biotechnology company expects revenue to be around GBP44.6 million, up 9% from GBP41.0 million in the previous year. Orders are expe

Soco International Chairman adds 50,000 shares

Soco International's Non-Executive Chairman, Rui de Sousa, has acquired 50,000 shares in the international oil and gas exploration and production company. The shares were purchased at 384.97p each for a total spend of £192,485. In its interim management statement last month the group said it was

Bioquell Says Some Divisions Ahead, But Cautions Asia Orders Hard To Forecast

Friday broker round-up UPDATE

Amlin: Berenberg raises target price from 398p to 434p, but still recommends selling. Barclays cuts target price from 481p to 453p and retains an overweight rating. Antofagasta: Numis raises target price from 750p to 850p and reiterates a hold recommendation. AstraZeneca: Liberum Capital upgrades

Bioquell Seeks New Finance Chief As Mark Bodeker Resigns

Thursday broker round-up UPDATE

AMEC: Nomura reduces target price from 1300p to 1230p, while reiterating its buy recommendation. Antofagasta: Exane cuts target price from 1200p to 1100p maintaining an outperform rating. Ashtead Group: JP Morgan shifts target price from 729p to 734p and keeps a neutral rating. Associated British

Tuesday broker round-up UPDATE

Admiral Group: Canaccord Genuity raises target price from 1050p to 1215p, but reiterates its sell recommendation. BAE Systems: Investec moves target price from 325p to 375p retaining a hold recommendation. Balfour Beatty: Numis lowers target price from 330p to 300p and downgrades to add. BHP Bill

Bioquell profits hit by problematic December

Bioquell, a company which provides specialist bio-decontamination technologies to a range of markets, has admitted it suffered a 'slight shortfall' at the end of the year in orders expected for immediate shipment to Life Sciences customers based in continental Europe. As a result, full year revenue

Monday broker round-up UPDATE

Aberdeen Asset Management: JP Morgan ups target price from 414p to 479p and retains an overweight rating. HSBC downgrades to neutral. Aggreko: UBS cuts target price from 2350p to 2250p maintaining a buy rating. ARM Holdings: Piper Jaffray downgrade to neutral. Ashmore Group: JP Morgan shifts ta

Overheads hurt profits at Bioquell

Despite a slow start in 2010 for bio-decontamination technology group Bioquell, revenues grew 1%, but higher overheads resulted in a 44% fall in profits. Revenue for the year ended 31 December grew to £39.4m, from £39.2m, while total orders increased 24% from £36.2m to £44.8m. The first half saw a

Promethean non-exec buys at discount to float

Non-executive director Philip Rowley has invested £31,000 in interactive whiteboards supplier Promethean World. Rowley bought 24,838 shares at 124.7p a share, taking his stake to 157,606 shares. Promethean World floated in March 2010 at 200p a share. The share price has been in decline since June

Capital and Counties bosses lay foundations

Bosses at Capital and Counties Properties have been opening their accounts in the real estate firm following its demerger from the property giant Liberty International. Chairman Ian Durant bought 122,347 shares at 1,21.7p a share, paying a total of £148,884, while chief executive Ian Hawksworth, to